Aspira Women's Health Inc. 8-K

What Happened

• Aspira Women’s Health Inc. announced on January 30, 2026 that it entered into a Subordinated Business Loan and Security Agreement with Agile Lending, LLC (lead lender) and Agile Capital Funding, LLC (collateral agent).
• The company issued a Subordinated Secured Promissory Note for $1,050,000; the Note carries total interest charges of $441,000 (assuming all payments are made on time) and matures on August 26, 2026.
• The Note is expressly subordinated to all senior indebtedness and is secured by a continuing security interest in substantially all of the company’s and certain co‑borrowers’ personal property (accounts, equipment, inventory, IP and other general intangibles), subject to customary exclusions. A financing statement may be filed only upon an event of default. Proceeds will be used for general corporate purposes.

Key Details

• Loan amount: $1,050,000; interest charges: $441,000 (if paid on schedule); maturity: August 26, 2026.
• Lenders: Agile Lending, LLC (lead) and Agile Capital Funding, LLC (collateral agent).
• Security: continuing lien on substantially all personal property of the company and co-borrowers; filing of financing statement limited until default.
• Note is subordinated to senior debt; agreement governed by Commonwealth of Virginia law; lenders have acceleration and remedy rights on default.

Why It Matters

• This transaction increases Aspira’s short‑term indebtedness with a secured, subordinated loan that carries significant interest cost relative to principal and a near‑term maturity (August 2026).
• The lien on substantially all personal property and the subordination to senior debt affect creditor priority and could influence the company’s future financing flexibility and liquidity planning. Investors should note the added debt, its cost, and the short maturity when evaluating near‑term cash needs and capital structure.